Cardiology Activities
Clinical Considerations When Using Direct Oral Anticoagulant Reversal Agents and the Role of the Pharmacist in Patient Monitoring
0290-0000-19-200-H01-P
This activity will explore the importance of assessing bleeding risk, monitoring patients, and working with health care providers to develop policies and procedures to effectively manage patients with DOAC-associated bleeds.
1.00
Uncovering the Cardiovascular Benefits of Therapeutic Options in Diabetes
0290-0000-19-191-H01-P
This activity will allow pharmacists to thoroughly understand the medications and their associated adverse effects to identify and alleviate patient fears and improve their quality of life.
1.00
The Role of the Health-System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulant Bleeding with Novel Reversal Agents
0290-0000-19-189-H01-P
The goal of this activity is to review the efficacy and safety of various available reversal agents as well as dosing, preparation, and administration.
1.00
Improving Transitions of Care in Heart Failure: The Role of Health-Systems and Community Pharmacists
0290-0000-19-184-H01-P
This on-demand webinar will examine the current status of heart failure, including readmissions rates and gaps in coordination of care
1.00